Learn about support and programs that may help you pay for GILOTRIF.

Learn how NSCLC is treated

The non-small cell lung cancer (NSCLC) treatment option your doctor chooses will depend on the characteristics of your lung cancer. This is one of the reasons doctors will take a sample, or biopsy, of the tumor. In addition to telling them what type of cancer you have, it also tells them if you have a specific genetic mutation. This information can help determine your treatment plan.

Today there are therapies available that block the signaling associated with specific genetic mutations in NSCLC that can cause cancer to grow and spread. Some of these genetic mutations involve epidermal growth factor receptor (EGFR), a molecule that is found in cancer and normal cells.


GILOTRIF is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC):

• that has certain types of abnormal epidermal growth factor receptor (EGFR) genes.  Your doctor will perform a test to check for certain types of abnormal EGFR genes, and make sure that GILOTRIF is right for you.  GILOTRIF may be used when you have not had previous treatment for cancer that has spread to other parts of the body.  It is not known if GILOTRIF is safe and effective in treating lung cancer with other abnormal EGFR genes.


• that is squamous type and has spread to other parts of the body after you have tried chemotherapy that contains platinum.

It is not known if GILOTRIF is safe and effective in children.